Neuroendocrine Tumor Liver Metastases Imaging Features and Therapy Outcomes

figshare admin karger published supplementary material on 2026-04 13. The dataset contains imaging review data from 219 patients across three therapy cohorts, analyzing associations between metastatic patterns and treatment outcomes. It includes categorized data on lesion number, maximum diameter, and tumor burden fraction.

Use Cases

• Correlating lesion size and number with treatment response based on RECIST criteria mentioned in the description.
• Modeling progression-free survival based on categorized tumor burden as a fraction of liver volume.
• Comparing outcomes between liver-directed therapy, systemic chemotherapy, and peptide receptor radionuclide therapy cohorts.
• Investigating treatment-by-stratum interactions for patient triaging as described in the methods.

Strengths

• Data from 219 patients across three distinct therapy cohorts provides a comparative basis.
• Includes specific outcome metrics: overall response rates of 65%, 38%, and 25%, and median progression-free survival times.
• Multivariable modeling was performed to test treatment-by-stratum interaction.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.
• Data may reflect temporal or institutional bias inherent to the specific clinical trials analyzed.

Provenance

Source

figshare admin karger

Collection Method

Image review and analysis from two multicenter prospective clinical trials and an institutional cohort.

Time Range

null

Freshness

Last updated 2026-04-13 07:55:14; freshness should be verified.

Geography

null